Related Experiment Video
Updated: Feb 21, 2026

10:42
Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
3.5K
Point-of-care Testing in Pediatric Infectious Diseases
The Pediatric Infectious Disease Journal
|October 13, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Pneumonia III: Complications and Assessment
949
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
949
Pharmacokinetics in Pediatric Patients: Drug Excretion
298
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
298
Pharmacokinetics in Pediatric Patients: Drug Distribution
350
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
350
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
346
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
346

